中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

21 records (took 0.016 seconds)

    USE OF LANOSTANE AND PORIA EXTRACT IN TREATING DIABETES
    11.
    发明申请
    USE OF LANOSTANE AND PORIA EXTRACT IN TREATING DIABETES 有权
    使用兰斯坦和波利亚提取物治疗糖尿病

    公开(公告)号：US20110053899A1

    公开(公告)日：2011-03-03

    申请号：US12854037

    申请日：2010-08-10

    Applicant: Hang-Ching Lin ,  Yu-Chuan Huang ,  Tsu-Chung Chang ,  Wen-Liang Chang

    Inventor： Hang-Ching Lin ,  Yu-Chuan Huang ,  Tsu-Chung Chang ,  Wen-Liang Chang

    IPC: A61K31/575 ,  A61P3/10

    CPC classification number: A61K31/575 ,  A61K36/076

    Abstract: A pharmaceutical composition for treating diabetes is provided in this invention. The composition contains a lanostane compound as a potent component. A suitable source of the lanostane compound is a Poria extract from metabolite, sclerotium, or fermentation product of Poria cocos (Schw) Wolf. The Poria extract contains 1-60% of the lanostane compounds by weight of the extract, and is devoid of secolanostane.

    Abstract translation: 本发明提供了用于治疗糖尿病的药物组合物。 组合物含有作为有效成分的羊毛甾醇化合物。 羊毛甾烷化合物的合适来源是茯苓（Schw）狼的代谢物，菌核或发酵产物的茯苓提取物。 茯苓提取物含有1-60％的羊毛甾烷化合物，其重量为提取物，并且没有塞可安烷。

    Pharmaceutical composition containing bakuchiol for treating woman osteoporosis
    12.
    发明授权
    Pharmaceutical composition containing bakuchiol for treating woman osteoporosis 有权
    含有治疗女性骨质疏松症的bakuchiol的药物组合物

    公开(公告)号：US07714026B2

    公开(公告)日：2010-05-11

    申请号：US11126234

    申请日：2005-05-11

    Applicant: Hang-Ching Lin ,  Hsiou-Yu Ding ,  Wen-Liang Chang ,  Chien-Lian Chao ,  Hsin-Wen Huang ,  Chin-Liang Lin

    Inventor： Hang-Ching Lin ,  Hsiou-Yu Ding ,  Wen-Liang Chang ,  Chien-Lian Chao ,  Hsin-Wen Huang ,  Chin-Liang Lin

    IPC: A61K31/05

    CPC classification number: A61K31/05

    Abstract: The present invention discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering osteoporosis. An embodiment of this novel use is a pharmaceutical composition containing bakuchiol or an extract containing bakuchiol, which can be in the dosage forms of topical use, oral administration, injection or sustained release. The present invention also discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering breast cancer.

    Abstract translation: 本发明公开了一种用于预防或治疗患有骨质疏松症的女性的bakuchiol或含有bakuchiol的提取物的新用途。 这种新用途的一个实施方案是含有bakuchiol或含有bakuchiol的提取物的药物组合物，其可以是局部使用，口服给药，注射或持续释放的剂型。 本发明还公开了一种新颖的使用bakuchiol或含有bakuchiol的提取物来预防或治疗患有乳腺癌的女性。

    USE OF LANOSTANE AND PORIA EXTRACT IN TREATING CACHEXIA
    18.
    发明申请
    USE OF LANOSTANE AND PORIA EXTRACT IN TREATING CACHEXIA 有权
    使用LANOSTANE和PORIA提取物处理CACHEXIA

    公开(公告)号：US20100279992A1

    公开(公告)日：2010-11-04

    申请号：US12771777

    申请日：2010-04-30

    Applicant: Hang-Ching Lin

    Inventor： Hang-Ching Lin

    IPC: A61K31/58 ,  A61K31/575 ,  A61P21/00 ,  A61P35/00 ,  A61P17/02

    CPC classification number: A61K9/1652 ,  A61K9/4866 ,  A61K31/575 ,  A61K36/076

    Abstract: A pharmaceutical composition for treating cachexia, and in particular for treating cancer cachexia. The composition contains a lanostane compound as a potent component. A suitable source of the lanostane compound is a Poria extract from metabolite, sclerotium, or fermentation product of Poria cocos (Schw) Wolf. The Poria extract contains 1-60% of the lanostane compounds by weight of the extract, and is devoid of secolanostane.

    Abstract translation: 用于治疗恶病质，特别是用于治疗恶病质的药物组合物。 该组合物含有羊毛甾醇化合物作为有效成分。 羊毛甾烷化合物的合适来源是茯苓（Schw）狼的代谢物，菌核或发酵产物的茯苓提取物。 茯苓提取物含有1-60％的羊毛甾烷化合物，其重量为提取物，并且没有塞可安烷。

    PHARMACEUTICAL COMPOSITION AND EXTRACT OF PORIA FOR TREATING A DISEASE INDUCED FROM IMMUNE DISORDER
    20.
    发明申请
    PHARMACEUTICAL COMPOSITION AND EXTRACT OF PORIA FOR TREATING A DISEASE INDUCED FROM IMMUNE DISORDER 审中-公开
    药物组合物和提取物治疗免疫异常诱发的疾病

    公开(公告)号：US20090318399A1

    公开(公告)日：2009-12-24

    申请号：US12473110

    申请日：2009-05-27

    Applicant: Hang-Ching Lin ,  Wen-Mein Wu

    Inventor： Hang-Ching Lin ,  Wen-Mein Wu

    IPC: A61K31/56

    CPC classification number: A61K31/56 ,  A61K36/076

    Abstract: The present invention discloses a novel use of a lanostane having the following formula (I) in treating a disease induced from immune disorder: wherein R1 is either H or CH3; R2 is OCOCH3, ═O or OH; R3 is H or OH; R4 is —C(═CH2)—C(CH3)2Ra, in which Ra is H or OH, or —CH═C(CH3)—Rb, in which Rb is CH3 or CH2OH; R5 is H or OH; and R6 is CH3 or CH2OH.

    Abstract translation: 本发明公开了具有下式（I）的羊毛甾醇在治疗由免疫疾病诱导的疾病中的新用途：其中R1是H或CH3; R2是OCOCH3，-O或OH; R3是H或OH; R4是-C（-CH2）-C（CH3）2Ra，其中Ra是H或OH，或-CH-C（CH3）-Rb，其中Rb是CH3或CH2OH; R5是H或OH; 并且R 6是CH 3或CH 2 OH。

Patent Agency Ranking